DALLAS--(뉴스와이어) 2019년 03월 13일 -- As one of the world’s leading skincare innovators in the direct selling and cosmetic industries, Mary Kay Inc. continues its decades-long commitment to skin science research as a sponsor of the 20th World Dermatology Congress. The event, held on March 13-14 in Singapore, brings together researchers, academicians and scientists from the dermatology community worldwide to exchange information on technological advances and new scientific achievements.
The theme for World Dermatology 2019 is “Exploring the New Approaches in Dermatology.” By bridging the gap between experts from across the globe, the event provides cutting-edge analysis, exploration and treatment of conditions identified with skin, hair and nails. The conference focuses on skin health, skin ailments, allergy manifestations, clinical dermatology and cosmetic dermatology.
David Gan, Senior Principal Scientist at Mary Kay Inc., will present some new insights in evaluating and understanding facial redness. Based on this work, Mary Kay scientists identified botanical extracts that help reduce the production of pro-inflammatory proteins and enzymes in the skin and developed a cosmetic formulation containing these extracts to effectively address facial redness. After four weeks of use, the cosmetic formula reduced overall facial redness and skin temperature in subjects with persistent skin irritation.
“As a skin biologist, I’m honored to share Mary Kay’s groundbreaking skin research related to facial redness with the broader scientific community,” said Gan. “At Mary Kay, there’s nothing more rewarding than addressing skin issues that impact women and creating innovative products that provide skin benefits consumers are searching for. The results of this continued research will help us make Mary Kay® products better as we consider the concerns and experience of our consumers.”
Mary Kay’s Research and Development team, led by Dr. Lucy Gildea, Mary Kay’s Chief Scientific Officer, comprises of distinguished scientists holding doctorates and other advanced degrees across multiple disciplines: skin biology, cell biology, chemistry, biochemistry and more. This team of scientists is committed to discovering the trends and technologies that enable the company to create irresistible products that deliver benefits to the consumers.
“Collaborating with the world’s leading skincare experts at the 20th World Dermatology Congress provides opportunities to share the latest technological advances and scientific breakthroughs on skin health,” said Dr. Gildea. “Our sponsorship of the World Dermatology Congress is one of a series of Mary Kay partnerships with the scientific and academic communities around the world and showcases our continued commitment to skin science research.”
Mary Kay stands at the forefront of innovation with more than 700 products in its global portfolio. With more than 1,500 patents for products, technologies and packaging designs, Mary Kay has fostered a culture of innovation and invests millions of dollars annually in research and development. The recent appointment of Dr. Lucy Gildea to the company’s executive team and the opening of Mary Kay’s new, state-of-the-art, U.S.-based global manufacturing and research and development facility further expands the top beauty brand’s leadership in science-based product development and innovation.
For more information about World Dermatology 2019, click here (http://bit.ly/2EZ5p52).
About Mary Kay
At Mary Kay, success lies in our dedication to irresistible products, a rewarding opportunity and positive community impact. For 55 years, Mary Kay has inspired women to achieve their entrepreneurial goals in nearly 40 countries. As a multibillion-dollar company, we offer the latest in cutting-edge skin care, bold color cosmetics and fragrances. Discover more reasons to love Mary Kay at marykay.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20190312005959/en/